Investigating suicidality across the autistic-catatonic continuum in a clinical sample of subjects with major depressive disorder and borderline personality disorder.
autistic-catatonic continuum
borderline personality disorder (BPD)
catatonia
catatonia spectrum
catatonic traits
major depression disorder (MDD)
mood disorder
suicide
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
12
2022
accepted:
04
05
2023
medline:
5
6
2023
pubmed:
5
6
2023
entrez:
5
6
2023
Statut:
epublish
Résumé
Recent literature has highlighted that catatonia may be more prevalent among psychiatric patients than previously thought, beginning from autism spectrum disorders (ASD), for which it has been suggested to represent a severe late consequence, but also among individuals with mood disorders and borderline personality disorder (BPD). Interestingly, one critical point shared by these conditions is the increased risk of suicidality. The aim of this study was to evaluate how the presence and the prevalence of catatonic symptoms may shape and correlate with suicidal risk in a sample of individuals with major depressive disorder (MDD) or BPD. We recruited two clinical samples of subjects (BPD and MDD) and a control group without a diagnosis according to DSM-5 (CTL). Subjects were assessed with the catatonia spectrum (CS) and the MOODS-SR for evaluating suicidality. In the total sample, suicidality score was significantly and positively correlated with all CS domains and CS total score. Correlation and regression analyses highlighted specific patterns of association among Catatonia spectrum domains and suicidality in the MDD and BPD group and in the total sample. In both disorders, higher catatonic traits are linked to higher suicidal tendencies, confirming the high risk of suicide for this population. However, different patterns of association between catatonic symptoms and suicidality were highlighted in the two disorders.
Sections du résumé
Background
UNASSIGNED
Recent literature has highlighted that catatonia may be more prevalent among psychiatric patients than previously thought, beginning from autism spectrum disorders (ASD), for which it has been suggested to represent a severe late consequence, but also among individuals with mood disorders and borderline personality disorder (BPD). Interestingly, one critical point shared by these conditions is the increased risk of suicidality. The aim of this study was to evaluate how the presence and the prevalence of catatonic symptoms may shape and correlate with suicidal risk in a sample of individuals with major depressive disorder (MDD) or BPD.
Methods
UNASSIGNED
We recruited two clinical samples of subjects (BPD and MDD) and a control group without a diagnosis according to DSM-5 (CTL). Subjects were assessed with the catatonia spectrum (CS) and the MOODS-SR for evaluating suicidality.
Results
UNASSIGNED
In the total sample, suicidality score was significantly and positively correlated with all CS domains and CS total score. Correlation and regression analyses highlighted specific patterns of association among Catatonia spectrum domains and suicidality in the MDD and BPD group and in the total sample.
Conclusion
UNASSIGNED
In both disorders, higher catatonic traits are linked to higher suicidal tendencies, confirming the high risk of suicide for this population. However, different patterns of association between catatonic symptoms and suicidality were highlighted in the two disorders.
Identifiants
pubmed: 37275986
doi: 10.3389/fpsyt.2023.1124241
pmc: PMC10234210
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1124241Informations de copyright
Copyright © 2023 Dell’Osso, Nardi, Bonelli, Gravina, Benedetti, Amatori, Battaglini, Massimetti, Luciano, Berardelli, Brondino, De Gregorio, Deste, Nola, Reitano, Muscatello, Pompili, Politi, Vita, Carmassi, Cremone, Carpita and Maj.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Acta Psychiatr Scand. 2017 Nov;136(5):441-444
pubmed: 28861900
Psychol Med. 2003 Apr;33(3):395-405
pubmed: 12701661
Clin Pract Epidemiol Ment Health. 2019 Aug 30;15:94-98
pubmed: 31819756
Eur Arch Psychiatry Clin Neurosci. 2001;251 Suppl 1:I8-13
pubmed: 11776271
Front Psychiatry. 2022 Aug 29;13:900277
pubmed: 36104987
Medicina (B Aires). 2020;80 Suppl 2:12-16
pubmed: 32150706
Ann Clin Psychiatry. 2005 Oct-Dec;17(4):205-10
pubmed: 16402752
Psychiatry Res. 2019 Nov;281:112605
pubmed: 31629303
Bipolar Disord. 2015 Dec;17(8):892-901
pubmed: 26643014
Arch Gen Psychiatry. 2006 Oct;63(10):1139-48
pubmed: 17015816
Mol Autism. 2020 Feb 10;11(1):14
pubmed: 32039740
CNS Spectr. 2022 Jun;27(3):272-280
pubmed: 33161925
Psychopathology. 1998;31(4):188-96
pubmed: 9697162
Compr Psychiatry. 2008 Jul-Aug;49(4):380-6
pubmed: 18555059
Am J Psychiatry. 2003 Jul;160(7):1233-41
pubmed: 12832234
CNS Spectr. 2021 Oct;26(5):437-439
pubmed: 32450944
No To Shinkei. 2005 Jan;57(1):45-9
pubmed: 15782600
Int J Environ Res Public Health. 2022 Mar 23;19(7):
pubmed: 35409492
J Affect Disord. 2003 May;74(3):279-85
pubmed: 12738047
Front Psychol. 2021 Feb 11;12:626353
pubmed: 33643157
Encephale. 2008 Oct;34(5):452-8
pubmed: 19068333
Psychol Med. 2012 Apr;42(4):783-94
pubmed: 22067328
Can J Psychiatry. 2009 Jul;54(7):437-45
pubmed: 19660165
J Abnorm Psychol. 1997 May;106(2):307-14
pubmed: 9131850
J Neurol Neurosurg Psychiatry. 1986 Sep;49(9):991-6
pubmed: 3760905
Gen Hosp Psychiatry. 2013 Jan-Feb;35(1):50-3
pubmed: 23141028
Am J Psychiatry. 2013 Jan;170(1):31-42
pubmed: 23223893
Neurosci Biobehav Rev. 2019 Jan;96:316-334
pubmed: 30500331
J Child Adolesc Psychopharmacol. 2021 Mar;31(2):144-146
pubmed: 33734906
Compr Psychiatry. 2012 May;53(4):333-40
pubmed: 21821235
BMC Psychol. 2022 Jul 15;10(1):173
pubmed: 35841077
J Neurol Neurosurg Psychiatry. 1996 Mar;60(3):326-32
pubmed: 8609512
Autism. 2018 Nov;22(8):907-914
pubmed: 28901163
Lancet. 2004 Jul 31-Aug 6;364(9432):453-61
pubmed: 15288745
Br J Psychiatry. 2018 May;212(5):279-286
pubmed: 29587888
J Autism Dev Disord. 2005 Jun;35(3):351-60
pubmed: 16119476
Front Psychiatry. 2022 May 12;13:913286
pubmed: 35633780
Biol Psychiatry. 2002 Dec 1;52(11):1102-12
pubmed: 12460693
Br J Psychiatry. 2000 Apr;176:357-62
pubmed: 10827884
J Autism Dev Disord. 2020 Oct;50(10):3638-3648
pubmed: 31820344
Brain Sci. 2021 May 12;11(5):
pubmed: 34066194
Eur Psychiatry. 2022 Nov 04;65(1):e81
pubmed: 36328964
Soins Pediatr Pueric. 2020 Mar - Apr;41(313):44-46
pubmed: 32446557
Ann Gen Psychiatry. 2021 Dec 16;20(1):54
pubmed: 34915925
Issues Compr Pediatr Nurs. 2007 Jul-Sep;30(3):87-107
pubmed: 17885828
Child Adolesc Psychiatr Clin N Am. 2019 Jan;28(1):111-120
pubmed: 30389071
J Pers Disord. 2013 Apr;27(2):172-95
pubmed: 23514182
Front Neurosci. 2022 Jan 13;15:756628
pubmed: 35095389
Encephale. 2001 Jan-Feb;27(1):22-7
pubmed: 11294035
Eur Arch Psychiatry Clin Neurosci. 2001;251 Suppl 1:I4-7
pubmed: 11776270
Australas Psychiatry. 2019 Dec;27(6):573-577
pubmed: 31573324
PLoS One. 2017 Sep 8;12(9):e0184447
pubmed: 28886113
J Autism Dev Disord. 2019 Oct;49(10):3939-3955
pubmed: 31147901
Medicina (Kaunas). 2019 May 28;55(6):
pubmed: 31142033
Schizophr Bull. 2010 Mar;36(2):231-8
pubmed: 19776208
Lancet. 2011 Jan 1;377(9759):74-84
pubmed: 21195251
Clin Psychol Rev. 2017 Nov;57:141-163
pubmed: 28941927
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(6. Vyp. 2):78-83
pubmed: 35797200
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jan;29(1):27-38
pubmed: 15610942
Vertex. 2012 Jul-Aug;23(104):312-20
pubmed: 23170304
Psychopathology. 2014;47(4):220-34
pubmed: 24577235
CNS Neurol Disord Drug Targets. 2023;22(4):462-465
pubmed: 35388766
Gen Psychiatr. 2021 Sep 3;34(5):e100494
pubmed: 34595400
J Autism Dev Disord. 2017 Aug;47(8):2519-2534
pubmed: 28527095
Acta Psychiatr Scand. 2012 Jan;125(1):33-8
pubmed: 22040029
Innov Clin Neurosci. 2011 Mar;8(3):14-8
pubmed: 21487541
J Pers Disord. 2005 Oct;19(5):505-23
pubmed: 16274279
Compr Psychiatry. 2018 May;83:7-11
pubmed: 29500962
J Autism Dev Disord. 2019 Mar;49(3):819-833
pubmed: 30361940
Eur Psychiatry. 2021 Dec 15;65(1):e4
pubmed: 34906264
Psychiatr Q. 2012 Sep;83(3):281-92
pubmed: 22020926